Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Preferred Dividend Payments (2022 - 2025)

Fortress Biotech (FBIO) has 4 years of Preferred Dividend Payments data on record, last reported at $2.2 million in Q3 2025.

  • For Q3 2025, Preferred Dividend Payments changed 0.05% year-over-year to $2.2 million; the TTM value through Sep 2025 reached $9.4 million, up 8.5%, while the annual FY2024 figure was $9.9 million, 23.17% up from the prior year.
  • Preferred Dividend Payments reached $2.2 million in Q3 2025 per FBIO's latest filing, up from $2.1 million in the prior quarter.
  • Across five years, Preferred Dividend Payments topped out at $2.9 million in Q4 2024 and bottomed at $2.0 million in Q2 2022.
  • Average Preferred Dividend Payments over 4 years is $2.2 million, with a median of $2.1 million recorded in 2022.
  • Peak YoY movement for Preferred Dividend Payments: skyrocketed 43.77% in 2024, then dropped 12.74% in 2025.
  • A 4-year view of Preferred Dividend Payments shows it stood at $2.0 million in 2022, then changed by 0.0% to $2.0 million in 2023, then surged by 43.77% to $2.9 million in 2024, then dropped by 24.7% to $2.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Preferred Dividend Payments were $2.2 million in Q3 2025, $2.1 million in Q1 2025, and $2.9 million in Q4 2024.